Ashley Gallagher is an associate editor for Pharmacy Times.
Why Are Companies Launching Biosimilars With 2 Prices? Julie Reed Explains
July 30th 2023Why are companies pricing their adalimumab biosimilars with 2 prices? Can the United States expect more of this pricing strategy for future biosimilar launches? Julie Reed, executive director of the Biosimilars Forum, has the answers.